Title: Canagliflozin, Newly Approved for Type 2 Diabetes, Appears to Be Effective
Abstract: When metformin monotherapy fails to control type 2 diabetes, the best choice for a second agent is unclear. The FDA recently approved another option:
Publication Year: 2013
Publication Date: 2013-07-25
Language: en
Type: article
Access and Citation
AI Researcher Chatbot
Get quick answers to your questions about the article from our AI researcher chatbot